
BioCentury
45 FOLLOWERS
BioCentury's most recent analysis is the authoritative resource to stay up to date with facts, explanations and interpretations. For three decades, BioCentury has given biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; industry-leading business intelligence; and global conferences.
BioCentury
9h ago
FEB 05, 2025 | 6:26 PM PST | BIOCENTURY | MANAGEMENT TRACKS
ARCTURUS APPOINTS SLAOUI CHAIR DESIGNATE
BY
Plus: Affinia hires Makimura and Xu joins Sciwindhttps://www.biocentury.com/article/654979/arcturus-appoints-slaoui-chair-designate© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 05, 2025 | 6:23 PM PST | BIOCENTURY | POLITICS, POLICY & LAW
BILL EXPANDING IRA ORPHAN EXEMPTION INTRODUCED
BY
ORPHAN Cures seeks to lift restriction on number of orphan indications exempt from Medicare price negotiationshttps://www.biocentury.com/article/654985/bill-expanding-ira-orphan-exemption-introduced© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 05, 2025 | 6:21 PM PST | BIOCENTURY | GUEST COMMENTARY
CALL TO ACTION: DEFENDING THE NIH, THE NSF AND THE FOUNDATION OF AMERICAN SCIENCE — A GUEST COMMENTARY
BY
There is an assault on the foundation of U.S. science: Silence is not an optionhttps://www.biocentury.com/article/654982/call-to-action-defending-the-nih-the-nsf-and-the-foundation-of-american-science-a-guest-commentary© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 05, 2025 | 5:29 PM PST | BIOCENTURY | PRODUCT DEVELOPMENT
CARDIOMETABOLIC WINS AMONG HIGHLIGHTS IN BIOCENTURY’S LATEST CLINICAL REPORT
BY
Plus readouts from Allakos, Leap, Cargo and morehttps://www.biocentury.com/article/654975/cardiometabolic-wins-among-highlights-in-biocentury-s-latest-clinical-report© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 05, 2025 | 5:05 PM PST | BIOCENTURY | MANAGEMENT TRACKS
ELEVAATE: CULTIVATING THE NEXT GENERATION OF EAST ASIAN AMERICAN LEADERS
BY
The non-profit launches to overcome C-suite underrepresentation by helping U.S. biopharma leaders of East Asian descent advance in their careershttps://www.biocentury.com/article/654632/elevaate-cultivating-the-next-generation-of-east-asian-american-leaders© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 05, 2025 | 4:55 PM PST | BIOCENTURY | PRODUCT DEVELOPMENT
NOVO BELIEVES NEW CAGRISEMA TRIAL CAN HIT WEIGHT LOSS GOAL
BY
Aims to drive additional weight loss after analysis of Phase III REDEFINE 1 obesity datahttps://www.biocentury.com/article/654974/novo-believes-new-cagrisema-trial-can-hit-weight-loss-goal© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 05, 2025 | 3:53 PM PST | BIOCENTURY | PRODUCT DEVELOPMENT
BIOTECHS MAKE INROADS TO PRECISION MEDICINE, SOLVING LONG-STANDING PROBLEMS
BY
70% of new precision medicines approved by FDA in past three years were not sponsored by major pharmashttps://www.biocentury.com/article/654884/biotechs-make-inroads-to-precision-medicine-solving-long-standing-problems© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
9h ago
FEB 04, 2025 | 12:30 PM PST | BIOCENTURY | FINANCE
AUSTRALIAN RADIOPHARMA PLAY ADVANCELL TAPS VCS FOR $112M IN ‘SCALE CAPITAL’
BY
Expanding in U.S., the biotech will build manufacturing capacity for α-emitters, including clinical program for prostate cancerhttps://www.biocentury.com/article/654951/australian-radiopharma-play-advancell-taps-vcs-for-112m-in-scale-capital© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
1d ago
FEB 04, 2025 | 5:35 PM PST | BIOCENTURY | MANAGEMENT TRACKS
MANAGEMENT CHANGES AT ASTELLAS
BY
Plus: Lundbeck board planning to elect Dorothea Wenzel chair, and updates from PacBio and Uvax Biohttps://www.biocentury.com/article/654953/management-changes-at-astellas© 2025 BioCentury Inc. All Rights Reserved ..read more
BioCentury
1d ago
FEB 04, 2025 | 5:07 PM PST | BIOCENTURY | POLITICS, POLICY & LAW
CASSIDY’S SUPPORT PAVES PATH FOR RFK JR. CONFIRMATION
BY
Vaccine critic, conspiracy promoter on track to be next HHS secretaryhttps://www.biocentury.com/article/654956/cassidy-s-support-paves-path-for-rfk-jr-confirmation© 2025 BioCentury Inc. All Rights Reserved ..read more